ID22978A - Antagonis reseptor endotelin - Google Patents

Antagonis reseptor endotelin

Info

Publication number
ID22978A
ID22978A IDW991588A ID991588A ID22978A ID 22978 A ID22978 A ID 22978A ID W991588 A IDW991588 A ID W991588A ID 991588 A ID991588 A ID 991588A ID 22978 A ID22978 A ID 22978A
Authority
ID
Indonesia
Prior art keywords
endotelin
receptor antagonists
antagonists
receptor
endotelin receptor
Prior art date
Application number
IDW991588A
Other languages
English (en)
Inventor
Dieter Dorsch
Mathias Osswald
Werner Mederski
Claudia Wilm
Maria Christadler
Claus Jochen Schmitges
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ID22978A publication Critical patent/ID22978A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/14—Thiadiazoles; Hydrogenated thiadiazoles condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/12—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
IDW991588A 1997-07-23 1999-04-22 Antagonis reseptor endotelin ID22978A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19731571A DE19731571A1 (de) 1997-07-23 1997-07-23 Endothelin-Rezeptor-Antagonisten

Publications (1)

Publication Number Publication Date
ID22978A true ID22978A (id) 1999-12-23

Family

ID=7836588

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991588A ID22978A (id) 1997-07-23 1999-04-22 Antagonis reseptor endotelin

Country Status (18)

Country Link
US (1) US6197800B1 (id)
EP (1) EP1000044A1 (id)
JP (1) JP2001510836A (id)
KR (1) KR20010022004A (id)
CN (1) CN1265102A (id)
AR (1) AR010933A1 (id)
AU (1) AU733338B2 (id)
BR (1) BR9811537A (id)
CA (1) CA2297315A1 (id)
DE (1) DE19731571A1 (id)
HU (1) HUP0003335A2 (id)
ID (1) ID22978A (id)
NO (1) NO20000324D0 (id)
PL (1) PL338070A1 (id)
SK (1) SK512000A3 (id)
TW (1) TW461887B (id)
WO (1) WO1999005132A1 (id)
ZA (1) ZA986551B (id)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1130027A1 (de) * 2000-02-29 2001-09-05 Aventis Pharma Deutschland GmbH Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben
RU2203277C2 (ru) * 2001-07-04 2003-04-27 Федеральное государственное унитарное предприятие "Государственный научный центр "Научно-исследовательский институт органических полупродуктов и красителей" Способ получения 5-хлор-2,1,3-бензотиадиазола
DE10155076A1 (de) * 2001-11-09 2003-05-22 Merck Patent Gmbh Verwendung von Endothelin-Rezeptor-Antagonisten zur Behandlung von Tumorerkrankungen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ271833A (en) * 1993-08-19 1997-08-22 Warner Lambert Co Substituted 2(5h)-furanone (or thiophenone or pyrrolone) derivatives
DE19509950A1 (de) * 1995-03-18 1996-09-19 Merck Patent Gmbh Endothelin-Rezeptor-Antagonisten
DE19607096A1 (de) * 1996-02-24 1997-08-28 Merck Patent Gmbh Endothelin-Rezeptor-Antagonisten

Also Published As

Publication number Publication date
SK512000A3 (en) 2000-07-11
AU8802298A (en) 1999-02-16
EP1000044A1 (de) 2000-05-17
CN1265102A (zh) 2000-08-30
BR9811537A (pt) 2000-08-29
DE19731571A1 (de) 1999-01-28
US6197800B1 (en) 2001-03-06
WO1999005132A1 (de) 1999-02-04
ZA986551B (en) 1999-09-20
HUP0003335A2 (hu) 2001-07-30
KR20010022004A (ko) 2001-03-15
PL338070A1 (en) 2000-09-25
CA2297315A1 (en) 1999-02-04
TW461887B (en) 2001-11-01
JP2001510836A (ja) 2001-08-07
AR010933A1 (es) 2000-07-12
NO20000324L (no) 2000-01-21
AU733338B2 (en) 2001-05-10
NO20000324D0 (no) 2000-01-21

Similar Documents

Publication Publication Date Title
ID19623A (id) Antagonis reseptor vitronektin
DE69812096D1 (de) Neuropeptid y rezeptorantagonisten
DK1009732T3 (da) 1-Amino-alkylcyclohexan NMDA receptor antagonister
DE69833073D1 (de) CCR-3-Rezeptor-Antagonisten
NO972016D0 (no) Indolyl-Y-reseptorantagonister
EP0986385A4 (en) GONADORELIN ANTAGONISTS
ID16742A (id) Antagonis reseptor endotelin
NO993586D0 (no) K-8 reseptor antagonister
DE69921351D1 (de) 4-aroyl-piperidin-ccr-3 rezeptor antagonisten iii
FI970107L (fi) Heterosyklisiä takykiniinireseptoriantagonisteja
ID24726A (id) Antagonis-antagonis reseptor trombin
NO993350D0 (no) Vitronectin-reseptor-antagonister
FI960953A7 (fi) Endoteliinireseptoriantagonisteja
EP0885205A4 (en) Fibrinogen Receptor Antagonists
ID26223A (id) Antagonis reseptor vitronektin
ID24162A (id) Antagonis-antagonis reseptor vitronektin
DK0906294T3 (da) Benzoxazinon-dopamin D4-receptor-antagonister
ID22838A (id) Oksazolidina sebagai antagonis 5-ht2a
DE69838874D1 (de) Il-8 rezeptor-antagonisten
ID28811A (id) Antagonis reseptor vitronektin
ID24468A (id) 2-asilaminopropanamina sebagai antagonis reseptor tachykinin
ATE303370T1 (de) Il-8 rezeptor antagonisten
DE69824837D1 (de) Il-8-rezeptor-antagonisten
ID24309A (id) 2-asilaminopropanamina sebagai antagonis reseptor tachykinin
DE69830671D1 (de) Integrin-rezeptor-antagonisten